Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 3/2013

01-09-2013 | Review Article

Identifying oncological emergencies

Authors: Achuta K. Guddati, Nilay Kumar, Ankur Segon, Parijat S. Joy, Creticus P. Marak, Gagan Kumar

Published in: Medical Oncology | Issue 3/2013

Login to get access

Abstract

Prompt identification and treatment of life-threatening oncological conditions is of utmost importance and should always be included in the differential diagnosis. Oncological emergencies can have a myriad of presentations ranging from mechanical obstruction due to tumor growth to metabolic conditions due to abnormal secretions from the tumor. Notably, hematologic and infectious conditions may complicate the presentation of oncological emergencies. Advanced testing and imaging is generally required to recognize these serious presentations of common malignancies. Early diagnosis and treatment of these conditions can significantly affect the patient’s clinical outcome.
Literature
1.
Yim CD, Sane SS, Bjarnason H. Superior vena cava stenting. Radiol Clin North Am. 2000;38(2):409–24.CrossRefPubMed
2.
Abrahm JL. Management of pain and spinal cord compression in patients with advanced cancer. ACP–ASIM End-of-life care consensus panel. American College of Physicians-American Society of Internal Medicine. Ann Intern Med. 1999;131(1):37–46.CrossRefPubMed
3.
4.
Allen KB, Faber LP, Warren WH, Shaar CJ. Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. Ann Thorac Surg. 1999;67(2):437–40.CrossRefPubMed
5.
6.
Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol. 1990;17(2):172–86.PubMed
7.
Sarris AH, Kempin S, Berman E, Michaeli J, Little C, Andreeff M, et al. High incidence of disseminated intravascular coagulation during remission induction of adult patients with acute lymphoblastic leukemia. Blood. 1992;79(5):1305–10.PubMed
8.
Bick RL. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am. 2003;17(1):149–76.CrossRefPubMed
9.
Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Passerini CG, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood. 1998;92(1):143–51.PubMed
10.
Coiffier B, Mounier N, Bologna S, Ferme C, Tilly H, Sonet A, et al. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin’s lymphoma: results of the GRAAL1 (Groupe d’Etude des lymphomes de l’adulte trial on rasburicase activity in adult lymphoma) study. J Clin Oncol. 2003;21(23):4402–6. doi:10.​1200/​JCO.​2003.​04.​115.CrossRefPubMed
11.
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52(4):427–31. doi:10.​1093/​cid/​ciq147.CrossRef
12.
Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med. 1975;135(5):715–9.CrossRefPubMed
13.
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis Off Publ Infect Dis Soc Am. 2002;34(6):730–51. doi:10.​1086/​339215.CrossRef
14.
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49(1):1–45. doi:10.​1086/​599376.CrossRef
15.
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011;52(4):e56–93. doi:10.​1093/​cid/​cir073.CrossRef
16.
Flynn PM, Van Hooser B, Gigliotti F. Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr Infect Dis J. 1988;7(7):510–3.CrossRefPubMed
17.
Allen U, Smith CR, Prober CG. The value of skin biopsies in febrile, neutropenic, immunocompromised children. Am J Dis Child. 1986;140(5):459–61.PubMed
18.
Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038–51.PubMed
19.
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the hospital infection control practices advisory committee (HICPAC). MMWR Recommendations and reports : morbidity and mortality weekly report recommendations and reports/Centers for Disease Control. 1995;44(RR-12):1–13.
20.
Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Off Publ Infect Dis Soc Am. 1992;14(6):1201–7.CrossRef
Metadata
Title
Identifying oncological emergencies
Authors
Achuta K. Guddati
Nilay Kumar
Ankur Segon
Parijat S. Joy
Creticus P. Marak
Gagan Kumar
Publication date
01-09-2013
Publisher
Springer US
Published in
Medical Oncology / Issue 3/2013
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-013-0669-6

Other articles of this Issue 3/2013

Medical Oncology 3/2013 Go to the issue

Original Paper

High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancer

Letter to the Editor

Is it all about cutoffs? Can DIC scores predict bleeding in APL?

Original Paper

Up-regulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues

Original Paper

The type of patients who would benefit from anti-androgen withdrawal therapy: could it be performed safely for aggressive prostate cancer?

Original Paper

High expression of Transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma

Letter to the Editor

t(15;17)(q22;q21), t(15;17)(q22;q12), or t(15;17)(q24;q21)? A diagnostic entity in search of unanimity
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits